Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Balaxi Pharmaceuticals Ltd

Your Vote -

Buy

28.57%

Hold

53.57%

Sell

17.86%

28.57%

28 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

41%

Sell Order Quantity

59%

Bid Price

Qty

57.46

2

57.00

8

57.00

43

57.00

40

57.00

10

Bid Total

24660

Bid Price

Qty

57.53

1

58.00

12

58.00

14

58.00

34

58.00

36

Bid Total

35024

Option Chain

Analyzes market sentiment, predicts Balaxi Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Balaxi Pharmaceutica has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    20 Apr 2025, 9:10AM As of March 2025, 65.99% is owned by Indian Promoters and 34.01% by Public. <p align=justify> Top four Promoters holding highest number of shares of B
  • Balaxi Pharmaceutica - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2025, 3:41PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Balaxi Pharmaceutica - Trading Window-XBRL

    29 Mar 2025, 11:09AM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window
  • Balaxi Pharmaceutica - Trading Window

    29 Mar 2025, 10:57AM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula
  • Balaxi Pharmaceutica - Shareholders meeting

    28 Mar 2025, 4:13PM BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers report of Postal Ballot along with Voting Results
  • Balaxi Pharmaceutica - Price movement

    10 Mar 2025, 6:03PM Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange, in order to ensure that investors have latest relevan
  • Balaxi Pharmaceutica - Price movement

    10 Mar 2025, 5:02PM Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange, in order to ensure that investors have latest relevan
  • Balaxi Pharmaceutica - Updates

    5 Mar 2025, 4:24PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding 'Submission of the unaudited financial results for the quarter and nine months ende
  • Balaxi Pharmaceutica - Copy of Newspaper Publication

    26 Feb 2025, 10:47AM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication
  • Balaxi Pharmaceutica - Notice Of Shareholders Meetings-XBRL

    25 Feb 2025, 5:15PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot
  • Balaxi Pharmaceutica - Shareholders meeting

    25 Feb 2025, 4:58PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Postal Ballot
  • Balaxi Pharmaceutica - Investor Presentation

    13 Feb 2025, 11:57AM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
  • Balaxi Pharmaceutica - Copy of Newspaper Publication

    11 Feb 2025, 12:38PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication
  • Balaxi Pharmaceutica - Integrated Filing- Financial

    10 Feb 2025, 10:50PM Integrated Filing (Financial)
  • Balaxi Pharmaceutica - Statement of deviation(s) or variation(s) under Reg. 32

    10 Feb 2025, 6:19PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Balaxi Pharmaceutica - Updates

    10 Feb 2025, 2:55PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding 'Board Comments on fine levied by the exchange'.
  • Balaxi Pharmaceutica - Outcome of Board Meeting

    10 Feb 2025, 2:39PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding outcome of Board meeting held on February 10, 2025.
  • Balaxi Pharmaceutica - Financial Result Updates

    10 Feb 2025, 2:38PM BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Balaxi Pharmaceutica Q3 net profit zooms 255.10% at Rs 1.74 cr

    10 Feb 2025, 5:00PM The company reported standalone net profit of Rs 1.74 crore for the quarter ended December 31, 2024 as compared to Rs 0.49 crore in the same period la
  • Balaxi Pharmaceutica - Board Meeting Intimation

    1 Feb 2025, 4:52PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2025 to consider and approve the Quarterly Unaudited

Key fundamentals

Evaluate the intrinsic value of Balaxi Pharmaceuticals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 135.5029 102.8575 59.843 46.7516 28.1123
Liabilities 135.5029 102.8575 59.843 46.7516 28.1123
Equity 10.8977 10.1813 10 10 10
Gross Profit 5.2363 16.8208 17.262 18.8875 6.4618
Net Profit 3.6503 16.2221 14.6674 15.1334 6.4958
Cash From Operating Activities -1.8307 -7.0662 8.8866 13.458 -14.3724
NPM(%) 5.2 15 14.48 17.42 14.23
Revenue 70.196 108.1376 101.2918 86.8711 45.6324
Expenses 64.9597 91.3168 84.0298 67.9836 39.1706
ROE(%) 1.69 7.51 6.79 7.01 3

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Balaxi Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Elgi Rubber Company Ltd 60.02 0.00 27.41 0.00 232.99 0.00
Gayatri Rubbers and Chemicals Ltd 452.00 0.04 116.80 0.00 27.18 0.00
Apar Industries Ltd 5600.00 -0.05 27.86 0.00 2054.13 0.91
Pix Transmissions Ltd 1466.00 -1.53 17.42 0.00 609.08 0.48

Company Info

The Anandam Rubber Co. Ltd. Incorporated in the year 1942 as a Public Ltd Company under The Travancore Companies Act 1114, having Registered office at Kottayam Taluk, Travancore. The Company incorporated as a plantation Company and acquired several Rubber and Tea plantations across South India namely, Anandam, Ennooramvayil, Ancheril, Elambramala and Pookkulam Estate. The main object clause of the Company also provides to carry on the business as an investment Company.In the year 1944, the Company made public issue (IPO) of equity shares and got listed at Madras Stock Exchange Ltd., Chennai. From the beginning itself our Company maintains good compliance record at MSE.The Company gave excellent returns to its members both by way of good dividend and bonus shares.The Company sold its last estate in the year 1989 and temporally existed from plantation business. From 1989 onwards the Company functions as an investment Company generating distributable profit as defined under section 205 of Companies Act 1956 and giving continuous dividend for last 15 years.In the year 2010, the present promoters took over the Company after complying with all provision of SEBI Takeover Code and continue to function as an Investment Company.The present board of the Company consists of persons having good experience in the fields of investment, Finance, Agriculture, Medicine.The Seven decade old Company have not undergone any reorganization, reconstruction, Amalgamation or name change during its long journey. 2017 -Company name has changed to Balaxi Ventures Ltd. from The Anandam Rubber Company Ltd.. 2020 -Company name has changed to Balaxi Pharmaceuticals Ltd. from Balaxi Ventures Ltd.. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-.

The Anandam Rubber Co. Ltd. Incorporated in the year 1942 as a Public Ltd Company under The Travancore Companies Act 1114, having Registered office at Kottayam Taluk, Travancore. The Company incorporated as a plantation Company and acquired several Rubber and Tea plantations across South India namely, Anandam, Ennooramvayil, Ancheril, Elambramala and Pookkulam Estate. The main object clause of the Company also provides to carry on the business as an investment Company.In the year 1944, the Company made public issue (IPO) of equity shares and got listed at Madras Stock Exchange Ltd., Chennai. From the beginning itself our Company maintains good compliance record at MSE.The Company gave excellent returns to its members both by way of good dividend and bonus shares.The Company sold its last estate in the year 1989 and temporally existed from plantation business. From 1989 onwards the Company functions as an investment Company generating distributable profit as defined under section 205 of Companies Act 1956 and giving continuous dividend for last 15 years.In the year 2010, the present promoters took over the Company after complying with all provision of SEBI Takeover Code and continue to function as an Investment Company.The present board of the Company consists of persons having good experience in the fields of investment, Finance, Agriculture, Medicine.The Seven decade old Company have not undergone any reorganization, reconstruction, Amalgamation or name change during its long journey. 2017 -Company name has changed to Balaxi Ventures Ltd. from The Anandam Rubber Company Ltd.. 2020 -Company name has changed to Balaxi Pharmaceuticals Ltd. from Balaxi Ventures Ltd.. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-.

Read More

Parent Organisation

Balaxi Pharmaceuticals Ltd.

Founded

28/09/1942

Managing Director

Mr.Ashish Maheshwari

NSE Symbol

BALAXIEQ

FAQ

The current price of Balaxi Pharmaceuticals Ltd is

The 52-week high for Balaxi Pharmaceuticals Ltd is

The market capitalization of Balaxi Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Balaxi Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Balaxi Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Balaxi Pharmaceuticals Ltd shares.

The CEO of Balaxi Pharmaceuticals Ltd is Mr.Ashish Maheshwari, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT